PURIFICATION FROM LIVER-MICROSOMES FROM UNTREATED CYNOMOLGUS MONKEYS OF CYTOCHROME P450 CLOSELY RELATED TO HUMAN CYTOCHROME P450 2B6

被引:0
|
作者
OHMORI, S
SHIRAKAWA, C
MOTOHASHI, K
YOSHIDA, H
ABE, H
NAKAMURA, T
HORIE, T
KITAGAWA, H
ASAOKA, K
RIKIHISA, T
KANAKUBO, O
KITADA, M
机构
[1] EISAI & CO LTD,TSUKUBA 33026,JAPAN
[2] KYOTO UNIV,PRIMATE RES INST,INUYAMA 484,JAPAN
[3] CHIBA UNIV HOSP,CHUO KU,CHIBA 260,JAPAN
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A cytochrome P450 (P450) (referred to as P450CMLa) was purified and characterized from hepatic microsomes from untreated cynomolgus monkeys (Macaca irus). The final preparation was electrophoretically homogeneous and its estimated minimum molecular mass was 49.5 kDa. The amino-terminal amino acid sequence of the protein (first 34 residues) closely resembled that of the protein encoded by the 2B6 cDNA from humans (94%). This protein was cross-reactive with antibodies raised against P450 2B1 (P450 b), P450 2B11 (P450 PBD-2), and P450GP-1, which were purified from hepatic microsomes from phenobarbital-pretreated rats, beagle dogs, and guinea pigs, respectively. Also, the antibody raised against P450CMLa was able to cross-react with P450 2B1, P450 2B11, and P450GP-1. P450CMLa was capable of catalyzing benzphetamine N-demethylation and testosterone 16beta-hydroxylation in a reconstituted system. Anti-P450CMLa antibody inhibited the activity of testosterone 16beta-hydroxylase but not the activities of testosterone 2beta- and 6beta-hydroxylases in liver microsomes from cynomolgus monkeys. The content of P450CMLa, as estimated by immunoblot analysis, was 70 pmol/mg (about 5% of total P450). The protein immunoreactive with the anti-P450CMLa antibody was also present in liver microsomes from Japanese monkeys, baboons, common marmosets, and common squirrel monkeys. In liver microsomes from common squirrel monkeys, the content of protein immunoreactive with the anti-P450CMLa antibody and the activity of testosterone 16beta-hydroxylase were effectively increased by pretreatment with phenobarbital. The antibody against P450CMLa strongly inhibited the activity of testosterone 16beta-hydroxylase in liver microsomes not only from untreated cynomolgus monkeys but also from phenobarbital- and pregnenolone 16alpha-carbonitrile-pretreated common squirrel monkeys. These results indicated that the P450CMLa purified here is very similar to the forms of P450 classified into the 2B subfamily, in its amino-terminal amino acid sequence, catalytic activities, and immunochemical properties.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 50 条
  • [1] Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes
    Bae, Soo Hyeon
    Kwon, Min Jo
    Choi, Eu Jin
    Zheng, Yu Fen
    Yoon, Kee Dong
    Liu, Kwang-Hyeon
    Bae, Soo Kyung
    CHEMICO-BIOLOGICAL INTERACTIONS, 2013, 205 (01) : 11 - 19
  • [2] CHARACTERIZATION OF CYTOCHROME-P-450 2B6 IN HUMAN LIVER-MICROSOMES
    MIMURA, M
    BABA, T
    YAMAZAKI, H
    OHMORI, S
    INUI, Y
    GONZALEZ, FJ
    GUENGERICH, FP
    SHIMADA, T
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (06) : 1048 - 1056
  • [3] Purification of cytochrome P450 2B1, NADPH cytochrome P450 reductase, and cytochrome b(5) from rat liver
    Rodionova, NA
    Laws, WR
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : MP313 - MP313
  • [4] Characterization of feline cytochrome P450 2B6
    Okamatsu, Gaku
    Komatsu, Tetsuya
    Ono, Yuka
    Inoue, Hiroki
    Uchide, Tsuyoshi
    Onaga, Takenori
    Endoh, Daiji
    Kitazawa, Takio
    Hiraga, Takeo
    Uno, Yasuhiro
    Teraoka, Hiroki
    XENOBIOTICA, 2017, 47 (02) : 93 - 102
  • [5] Immunochemical Detection of Cytochrome P450 Enzymes in Liver Microsomes of 27 Cynomolgus Monkeys
    Uehara, Shotaro
    Murayama, Norie
    Nakanishi, Yasuharu
    Zeldin, Darryl C.
    Yamazaki, Hiroshi
    Uno, Yasuhiro
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02): : 654 - 661
  • [6] Comparison of In Vitro Metabolism of Ticlopidine by Human Cytochrome P450 2B6 and Rabbit Cytochrome P450 2B4
    Talakad, Jyothi C.
    Shah, Manish B.
    Walker, Gregory S.
    Xiang, Cathie
    Halpert, James R.
    Dalvie, Deepak
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (03) : 539 - 550
  • [7] Purification and characterization of a cytochrome P450 from liver microsomes of Xenopus laevis
    Saito, H
    Ohi, H
    Sugata, E
    Murayama, N
    Fujita, Y
    Higuchi, S
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 345 (01) : 56 - 64
  • [8] PURIFICATION AND PROPERTIES OF CYTOCHROME-P-450 FROM UNTREATED MONKEY LIVER-MICROSOMES
    OHMORI, S
    MOTOHASHI, K
    KITADA, M
    KANAKUBO, Y
    IGARASHI, T
    UENO, K
    KITAGAWA, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 125 (03) : 1089 - 1095
  • [9] Inhibitory monoclonal antibody to human cytochrome P450 2B6
    Yang, TJ
    Krausz, KW
    Shou, MG
    Yang, SK
    Buters, JTM
    Gonzalez, FJ
    Gelboin, HV
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (10) : 1633 - 1640
  • [10] Mechanism of inactivation of human cytochrome p450 2B6 by phencyclidine
    Jushchyshyn, Monica I.
    Wahlstrom, Jan L.
    Hollenberg, Paul F.
    Wienders, Larry C.
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (09) : 1523 - 1529